D.A. Davidson & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,400
Closed -$240K 1135
2017
Q4
$240K Buy
+5,400
New +$246K 0.01% 936
2017
Q1
Sell
-757
Closed -$39K 2451
2016
Q4
$39K Sell
757
-17
-2% -$820 ﹤0.01% 1700
2016
Q3
$37K Buy
774
+342
+79% +$17.3K ﹤0.01% 1646
2016
Q2
$23K Sell
432
-25
-5% -$1.38K ﹤0.01% 1715
2016
Q1
$24K Sell
457
-215
-32% -$10.6K ﹤0.01% 1656
2015
Q4
$34K Sell
672
-187
-22% -$9.29K ﹤0.01% 1537
2015
Q3
$38K Sell
859
-577
-40% -$27.3K ﹤0.01% 1477
2015
Q2
$65K Sell
1,436
-696
-33% -$30.5K ﹤0.01% 1324
2015
Q1
$91K Sell
2,132
-612
-22% -$23.3K ﹤0.01% 1179
2014
Q4
$95K Buy
2,744
+413
+18% +$13.7K ﹤0.01% 1160
2014
Q3
$75K Sell
2,331
-540
-19% -$18.1K ﹤0.01% 1242
2014
Q2
$97K Buy
2,871
+209
+8% +$6.7K ﹤0.01% 1153
2014
Q1
$72K Buy
+2,662
New +$79.1K ﹤0.01% 1276
2013
Q3
Sell
-175
Closed -$5K 1767
2013
Q2
$5K Buy
+175
New +$4.93K ﹤0.01% 1527

Other funds holding PBH

D.A. Davidson & Co's PBH Position: Q1 2018 in Review

D.A. Davidson & Co sold out of Prestige Consumer Healthcare (PBH) in Q1 2018, closing a stake of 5,400 shares — an estimated $240K sold.

D.A. Davidson & Co first reported a position in PBH in Q2 2013 and held it in 14 quarters. The position peaked at $240K in Q4 2017. 239 funds tracked by Wall St. Rank hold PBH as of Q1 2018.

  • D.A. Davidson & Co reported no remaining Prestige Consumer Healthcare position as of Q1 2018 after selling out during the quarter.
  • D.A. Davidson & Co sold 5,400 Prestige Consumer Healthcare shares in Q1 2018, an estimated $240K.
  • D.A. Davidson & Co first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 14 quarters.
  • D.A. Davidson & Co's Prestige Consumer Healthcare position peaked at $240K in Q4 2017.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2018.

Based on D.A. Davidson & Co's 13F filing for Q1 2018, filed 4 May 2018.